Shenzhen YHLO Biotech Co., Ltd.

SHSE:688575 Voorraadrapport

Marktkapitalisatie: CN¥10.4b

Shenzhen YHLO Biotech Beheer

Beheer criteriumcontroles 3/4

De CEO Shenzhen YHLO Biotech is Yongbo Song, benoemd in Dec2012, heeft een ambtstermijn van 11.92 jaar. bezit rechtstreeks 0.22% van de aandelen van het bedrijf, ter waarde CN¥ 22.32M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 8 jaar en 11.9 jaar.

Belangrijke informatie

Yongbo Song

Algemeen directeur

CN¥949.8k

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO11.9yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijn8yrs
Gemiddelde ambtstermijn bestuur11.9yrs

Recente managementupdates

Recent updates

We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings

Nov 06
We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings

Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch

Nov 04
Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch

Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)

Oct 31
Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)

Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return

Oct 12
Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return

Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings

Aug 30
Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings

Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?

Jul 18
Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?

Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing

May 23
Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing

Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 01
Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems

There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital

Mar 19
There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital

CEO

Yongbo Song (40 yo)

11.9yrs

Tenure

CN¥949,844

Compensatie

Mr. Yongbo Song serves as Vice Chairman of the Board at Shenzhen YHLO Biotech Co., Ltd., since March 2019 and serves as General Manager and Director since December 2012.


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Yongbo Song
GM & Vice Chairman of the Board11.9yrsCN¥949.84k0.22%
CN¥ 22.3m
Lisheng Liao
CFO & Director1.9yrsCN¥827.95k0.015%
CN¥ 1.5m
Yujing Xiao
Deputy General Manager8yrsCN¥1.62m0.43%
CN¥ 44.6m

8.0yrs

Gemiddelde duur

45yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 688575 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Yongbo Song
GM & Vice Chairman of the Board11.9yrsCN¥949.84k0.22%
CN¥ 22.3m
Lisheng Liao
CFO & Director1.9yrsCN¥827.95k0.015%
CN¥ 1.5m
Chunmao Shi
Independent Director1.1yrsCN¥22.50kgeen gegevens
Kunhui Hu
Chairman of the Board11.9yrsCN¥565.23k47.19%
CN¥ 4.9b
Xiaohui Ip
Chairman of the Supervisory Board11.9yrsgeen gegevensgeen gegevens

11.9yrs

Gemiddelde duur

45yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 688575 zijn ervaren en ervaren (gemiddelde ambtstermijn van 11.9 jaar).